Gaithersburg, MD, United States of America

Partha S Chowdhury

This inventor holds 31 USPTO granted patents and 18 published patent applications, plus 4 CIPO patents and 13 EPO patents, primarily in Biopharmaceuticals. Top assignees: Medimmune Limited, The United States of America, as Represented by the Secretary, Department of Health and Human Services, Boston Pharmaceuticals, Inc.. Active years: 2004-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Partha S Chowdhury. Retrieved from https://idiyas.com/inventor/partha-s-chowdhury

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31 (Patent Applications = 18)

% Patents Active = 93.5

CIPO Patents = 4 (Patent Applications = 7)

EPO Patents = 13 (Patent Applications = 12)

Average Co-Inventor Count = 4.9

ph-index = 10

Forward Citations = 262(Granted Patents)

Location History:

Rockville, MD (US) (2004 - 2010)
Fremont, CA (US) (2010)
Gaithersburg, MD (US) (2009 - 2023)

Company Filing History:

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

3 out of 3

Boston Pharmaceuticals, Inc.

Abbott Laboratories Corporation

patents

6. 1 out of 12

Horizon Therapeutics Ireland Dac

patents

7. 1 out of 676

Human Genome Sciences, Inc.

patents

8. 1 out of 18

Syniverse Icx Corporation

patents

where one patent can have more than one assignee

Years Active: 2004-2026

Loading Chart...

Areas of Expertise:

Immunocytokines

Monoclonal Antibodies

Binding Molecules

Combination Therapies

Pseudomonas

IL-21

HER3

DPP-4

Bispecific Antibody

Mesothelin

Polynucleotides

Antigen Binding Fragments

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12649782 - IMMUNOCYTOKINES FOR TREATMENT OF AUTOIMMUNE AND INFLAMMATORY CONDITIONS (2026-06-09),

2. 12428473 - Combination therapies using anti-pseudomonas PSL and PCRV binding molecules (2025-09-30),

3. 11608375 - Binding molecules specific for ASCT2 and uses thereof (2023-03-21),

4. 11529415 - Antibodies specific for IL-21 and uses thereof (2022-12-20),

5. 11447543 - [object Object] (2022-09-20),

6. 11305012 - Binding molecules specific for HER3 and uses thereof (2022-04-19),

7. 11203633 - Polynucleotides encoding antibodies or antigen binding fragments thereof that bind pseudomonas perv (2021-12-21),

8. 11091554 - Binding molecules specific for HER3 and uses thereof (2021-08-17),

9. 10829554 - Binding molecules specific for ASCT2 and uses thereof (2020-11-10),

10. 10775388 - Methods of using antibodies to determine periostin levels in a sample (2020-09-15),

11. 10730934 - Antibodies tosurface determinants (2020-08-04),

12. 10597439 - Combination therapies using anti-pseudomonas PSL and PCRV binding molecules (2020-03-24),

13. 10588969 - Antibodies specific for IL-21 and uses thereof (2020-03-17),

14. 10351630 - Assay to detect human DPP-4 (2019-07-16),

15. 10040857 - Binding molecules specific for HER3 and uses thereof (2018-08-07),

Title: The Innovative Journey of Partha S Chowdhury

Introduction:

Partha S Chowdhury, a talented inventor based in Gaithersburg, MD (US), has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents:

Partha S Chowdhury's latest patents include cutting-edge solutions in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise.

Career Highlights:

With over two decades of experience in research and development, Partha S Chowdhury has held key positions in renowned tech companies, where he spearheaded projects that have revolutionized industries.

Collaborations:

Throughout his career, Partha S Chowdhury has collaborated with leading universities and research institutions to further his inventions, demonstrating his commitment to pushing the boundaries of innovation.

Conclusion:

Partha S Chowdhury's relentless pursuit of innovation and his passion for creating solutions that make a difference highlight him as a visionary inventor shaping the future of technology.

Profile summary based on public USPTO records.